J 2023

Assessing the risk of bias of quantitative analytical studies: introducing the vision for critical appraisal within JBI systematic reviews

MUNN, Zachary, Jennifer C STONE, Edoardo AROMATARIS, Miloslav KLUGAR, Kim SEARS et. al.

Basic information

Original name

Assessing the risk of bias of quantitative analytical studies: introducing the vision for critical appraisal within JBI systematic reviews

Authors

MUNN, Zachary (guarantor), Jennifer C STONE, Edoardo AROMATARIS, Miloslav KLUGAR (203 Czech Republic, belonging to the institution), Kim SEARS, Jo LEONARDI-BEE and Timothy Hugh BARKER

Edition

JBI Evidence Synthesis, PHILADELPHIA, Wolters Kluwer Health, 2023, 2689-8381

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30230 Other clinical medicine subjects

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 2.700 in 2022

RIV identification code

RIV/00216224:14110/23:00133379

Organization unit

Faculty of Medicine

UT WoS

000945987900002

Keywords in English

critical appraisal; methodological quality; risk of bias; systematic reviews

Tags

International impact, Reviewed
Změněno: 1/2/2024 12:23, Mgr. Tereza Miškechová

Abstract

V originále

A key step in the systematic review process is the assessment of the methodological quality (or risk of bias) of the included studies. At JBI, we have developed several tools to assist with this evaluation. As evidence synthesis methods continue to evolve, it has been necessary to revise and reflect on JBI's current approach to critical appraisal and to plan a strategy for the future. In this first paper of a series focusing on risk of bias assessment, we introduce our vision for risk of bias assessment for JBI. In future papers in this series, the methodological approach taken for this revision process will be discussed, along with the revised tools and guidance for using these tools.

Links

LTC20031, research and development project
Name: Towards an International Network for Evidence-based Research in Clinical Health Research in the Czech Republic
Investor: Ministry of Education, Youth and Sports of the CR, INTER-COST